Wei Zhou et al.
FULL PAPERS
133.20, 130.28, 129.17, 125.12, 121.97, 121.65, 114.26, 60.66,
56.03, 13.66; HR-MS (ESI): m/z=258.1133 ([MH]+), calcd.
for C15H16NO3: 258.1130.
Ethyl 4-(pyridin-2-yl)-[1,1’-biphenyl]-3-carboxylate (3g):
1H NMR (400 MHz, CDCl3): d=8.69 (d, J=4.4, 1H), 8.09
Ethyl
4-methoxy-2-(pyridin-2-yl)benzoate
(3c):[8]
1H NMR (400 MHz, CDCl3): d=8.65 (d, J=4.4 Hz, 1H),
(s, 1H), 7.81–7.75 (m, 2H), 7.69–7.64 (m, 3H), 7.54–7.47 (m,
3H), 7.42–7.38 (m, 1H), 7.30–7.27 (m, 1H), 4.19 (q, J=
6.8 Hz, 2H), 1.09 (t, J=7.2 Hz, 3H); 13C NMR (100 MHz,
CDCl3): d=168.74, 158.40, 148.94, 141.26, 139.63, 139.52,
136.15, 132.31, 130.21, 129.41, 128.86, 128.37, 127.83, 127.10,
122.77, 121.96, 60.97, 13.76; HR-MS (ESI): m/z=304.1343
([MH]+), calcd. for C20H18NO2: 304.1338.
7.90 (d, J=8.4 Hz, 1H), 7.74–7.70 (m, 1H), 7.39 (d, J=
8.0 Hz, 1H), 7.29–7.25 (m, 1H), 7.00–6.95 (m, 2H), 4.09 (q,
J=7.2 Hz, 2H), 3.87 (s, 3H), 1.03 (t, J=7.2 Hz, 3H);
13C NMR (100 MHz, CDCl3): d=167.58, 161.76, 159.33,
148.79, 143.78, 135.83, 132.23, 123.24, 123.16, 121.96, 115.41,
113.61, 60.48, 55.48, 13.76.
Ethyl 5-chloro-2-(pyridin-2-yl)benzoate (3h):[11] 1H NMR
(400 MHz, CDCl3): d=8.64 (d, J=4.4 Hz, 1H), 7.81 (d, J=
Ethyl
5-methoxy-2-(pyridin-2-yl)benzoate
(3d):[10]
1H NMR (400 MHz, CDCl3): d=8.61 (d, J=4.8 Hz, 1H),
1.6 Hz, 1H), 7.77–7.73 (m, 1H), 7.54–7.48 (m, 2H), 7.44 (d,
J=7.6 Hz, 1H), 7.29–7.26 (m, 1H), 4.15 (q, J=7.2 Hz, 2H),
1.08 (t, J=6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=
167.39, 157.60, 149.03, 139.25, 136.25, 134.38, 133.27, 131.04,
130.93, 129.71, 122.73, 122.22, 61.25, 13.72.
7.73–7.69 (m, 1H), 7.49 (d, J=8.4 Hz, 1H), 7.43 (d, J=
8.0 Hz, 1H), 7.34 (d, J=2.8 Hz, 1H), 7.23–7.20 (m, 1H),
7.09–7.06 (m, 1H), 4.14 (q, J=7.2 Hz, 2H), 3.88 (s, 3H),
1.05 (t, J=6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=
168.70, 159.49, 158.48, 148.85, 136.02, 133.36, 133.08, 130.98,
122.60, 121.51, 116.87, 114.61, 60.97, 55.54, 13.72.
Ethyl 5-fluoro-2-(pyridin-2-yl)benzoate (3i):
(400 MHz, CDCl3): d=8.64 (d, J=4.4 Hz, 1H), 7.76–7.72
1H NMR
Ethyl 4-methyl-2-(pyridin-2-yl)benzoate (3e):[8] 1H NMR
(400 MHz, CDCl3): d=8.64 (d, J=4.4 Hz, 1H), 7.78 (d, J=
(m, 1H), 7.56–7.51 (m, 2H), 7.43 (d, J=8.0 Hz, 1H), 7.28–
7.22 (m, 2H), 4.15 (q, J=7.2 Hz, 2H), 1.07 (t, J=7.2 Hz,
3H); 13C NMR (100 MHz, CDCl3): d=167.27 (d, J=
2.5 Hz), 162.23 (d, J=247.7 Hz), 157.80, 148.87, 137.41 (d,
J=3.5 Hz), 136.22, 133.59 (d, J=17.4 Hz), 131.64 (d, J=
7.9 Hz), 122.82, 122.05, 117.89 (d, J=21.7 Hz), 116.76 (d, J=
23.5 Hz), 61.19, 13.66; HR-MS (ESI): m/z=246.0933
([MH]+), calcd. for C14H13FNO2: 246.0930.
8.0 Hz, 1H), 7.74–7.69 (m, 1H), 7.41 (d, J=8.0 Hz, 1H),
7.34 (s, 1H), 7.27–7.23 (m, 2H), 4.11 (q, J=7.2 Hz, 2H),
2.43 (s, 3H), 1.04 (t, J=7.2 Hz, 3H); 13C NMR (100 MHz,
CDCl3): d=168.36, 159.25, 148.87, 141.58, 141.31, 135.83,
130.61, 130.01, 128.80, 128.54, 122.98, 121.78, 60.63, 21.34,
13.73.
Ethyl 2-(3-methylpyridin-2-yl)benzoate (3j):[11] 1H NMR
(400 MHz, CDCl3): d=8.47 (d, J=4.8 Hz, 1H), 8.06 (d, J=
Ethyl 5-methyl-2-(pyridin-2-yl)benzoate (3f:)[8] 1H NMR
(400 MHz, CDCl3): d=8.64 (d, J=4.8 Hz, 1H), 7.73–7.69
8.0 Hz, 1H), 7.61–7.54 (m, 2H), 7.50–7.46 (m, 1H), 7.32 (d,
J=7.6 Hz, 1H), 7.22–7.19 (m, 1H), 4.07 (q, J=7.2 Hz, 2H),
2.12 (s, 3H), 1.01 (t, J=7.2 Hz, 3H); 13C NMR (100 MHz,
CDCl3): d=168.89, 159.59, 146.08, 141.80, 137.15, 131.89,
131.13, 130.42, 129.99, 129.87, 127.91, 122.12, 60.66, 19.13,
13.69.
(m, 1H), 7.65 (s, 1H), 7.44–7.41 (m, 2H), 7.35–7.33 (m, 1H),
7.24–7.21 (m, 1H), 4.12 (q, J=7.2 Hz, 2H), 2.42 (s, 3H),
1.04 (t, J=7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=
168.75, 158.67, 148.66, 138.20, 137.93, 136.04, 131.57, 131.50,
130.16, 129.60, 122.73, 121.68, 60.71, 20.88, 13.66.
Ethyl 2-(4-methylpyridin-2-yl)benzoate (3k):[21] 1H NMR
(400 MHz, CDCl3): d=8.48 (d, J=4.8 Hz, 1H), 7.82 (d, J=
6
ꢁ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 0000, 000, 0 – 0
ÝÝ
These are not the final page numbers!